Pain in cancer may come from compressing or infiltrating nearby body parts, from treatments and diagnostic procedures or from skin, nerve, and the other changes caused by a hormone imbalance or immune response.
Scope of the Report:
The report, states that opioids will continue to dominate as a breakthrough cancer pain treatment, mostly due to available generics and physician familiarity.
The worldwide market for Cancer Pain is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Cancer Pain in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
BioDelivery Science
ProStrakan Group
Teva pharmaceuticals
Eli-Lilly
Grunenthal Group
GW Pharmaceuticals
Johnson&Johnson
Meda Pharmaceuticals
Orexo
Sanofi
WEX Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Opioids
Non-Steroidal Anti-Inflammatory Drugs
Others
Market Segment by Applications, can be divided into
Paracetamol Treatment-Related Immunotherapy
Radiotherapy
Chemotherapy
Hormone Therapy
There are 15 Chapters to deeply display the global Cancer Pain market.
Chapter 1, to describe Cancer Pain Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cancer Pain, with sales, revenue, and price of Cancer Pain, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Pain, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cancer Pain market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cancer Pain sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Cancer Pain Introduction
1.2 Market Analysis by Type
1.2.1 Opioids
1.2.2 Non-Steroidal Anti-Inflammatory Drugs
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Paracetamol Treatment-Related Immunotherapy
1.3.2 Radiotherapy
1.3.3 Chemotherapy
1.3.4 Hormone Therapy
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 BioDelivery Science
2.1.1 Business Overview
2.1.2 Cancer Pain Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 BioDelivery Science Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 ProStrakan Group
2.2.1 Business Overview
2.2.2 Cancer Pain Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 ProStrakan Group Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Teva pharmaceuticals
2.3.1 Business Overview
2.3.2 Cancer Pain Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva pharmaceuticals Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli-Lilly
2.4.1 Business Overview
2.4.2 Cancer Pain Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli-Lilly Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Grunenthal Group
2.5.1 Business Overview
2.5.2 Cancer Pain Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Grunenthal Group Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 GW Pharmaceuticals
2.6.1 Business Overview
2.6.2 Cancer Pain Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GW Pharmaceuticals Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Johnson&Johnson
2.7.1 Business Overview
2.7.2 Cancer Pain Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Johnson&Johnson Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Meda Pharmaceuticals
2.8.1 Business Overview
2.8.2 Cancer Pain Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Meda Pharmaceuticals Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Orexo
2.9.1 Business Overview
2.9.2 Cancer Pain Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Orexo Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sanofi
2.10.1 Business Overview
2.10.2 Cancer Pain Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sanofi Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 WEX Pharmaceuticals
2.11.1 Business Overview
2.11.2 Cancer Pain Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 WEX Pharmaceuticals Cancer Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cancer Pain Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cancer Pain Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cancer Pain Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cancer Pain Manufacturer Market Share in 2017
3.3.2 Top 6 Cancer Pain Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cancer Pain Market Analysis by Regions
4.1 Global Cancer Pain Sales, Revenue and Market Share by Regions
4.1.1 Global Cancer Pain Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cancer Pain Revenue and Market Share by Regions (2013-2018)
4.2 North America Cancer Pain Sales and Growth Rate (2013-2018)
4.3 Europe Cancer Pain Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Pain Sales and Growth Rate (2013-2018)
4.5 South America Cancer Pain Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Pain Sales and Growth Rate (2013-2018)
5 North America Cancer Pain by Countries
5.1 North America Cancer Pain Sales, Revenue and Market Share by Countries
5.1.1 North America Cancer Pain Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cancer Pain Revenue and Market Share by Countries (2013-2018)
5.2 United States Cancer Pain Sales and Growth Rate (2013-2018)
5.3 Canada Cancer Pain Sales and Growth Rate (2013-2018)
5.4 Mexico Cancer Pain Sales and Growth Rate (2013-2018)
6 Europe Cancer Pain by Countries
6.1 Europe Cancer Pain Sales, Revenue and Market Share by Countries
6.1.1 Europe Cancer Pain Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cancer Pain Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cancer Pain Sales and Growth Rate (2013-2018)
6.3 UK Cancer Pain Sales and Growth Rate (2013-2018)
6.4 France Cancer Pain Sales and Growth Rate (2013-2018)
6.5 Russia Cancer Pain Sales and Growth Rate (2013-2018)
6.6 Italy Cancer Pain Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cancer Pain by Countries
7.1 Asia-Pacific Cancer Pain Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cancer Pain Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cancer Pain Revenue and Market Share by Countries (2013-2018)
7.2 China Cancer Pain Sales and Growth Rate (2013-2018)
7.3 Japan Cancer Pain Sales and Growth Rate (2013-2018)
7.4 Korea Cancer Pain Sales and Growth Rate (2013-2018)
7.5 India Cancer Pain Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer Pain Sales and Growth Rate (2013-2018)
8 South America Cancer Pain by Countries
8.1 South America Cancer Pain Sales, Revenue and Market Share by Countries
8.1.1 South America Cancer Pain Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cancer Pain Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cancer Pain Sales and Growth Rate (2013-2018)
8.3 Argentina Cancer Pain Sales and Growth Rate (2013-2018)
8.4 Colombia Cancer Pain Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cancer Pain by Countries
9.1 Middle East and Africa Cancer Pain Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cancer Pain Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cancer Pain Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cancer Pain Sales and Growth Rate (2013-2018)
9.3 UAE Cancer Pain Sales and Growth Rate (2013-2018)
9.4 Egypt Cancer Pain Sales and Growth Rate (2013-2018)
9.5 Nigeria Cancer Pain Sales and Growth Rate (2013-2018)
9.6 South Africa Cancer Pain Sales and Growth Rate (2013-2018)
10 Global Cancer Pain Market Segment by Type
10.1 Global Cancer Pain Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cancer Pain Sales and Market Share by Type (2013-2018)
10.1.2 Global Cancer Pain Revenue and Market Share by Type (2013-2018)
10.2 Opioids Sales Growth and Price
10.2.1 Global Opioids Sales Growth (2013-2018)
10.2.2 Global Opioids Price (2013-2018)
10.3 Non-Steroidal Anti-Inflammatory Drugs Sales Growth and Price
10.3.1 Global Non-Steroidal Anti-Inflammatory Drugs Sales Growth (2013-2018)
10.3.2 Global Non-Steroidal Anti-Inflammatory Drugs Price (2013-2018)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2013-2018)
10.4.2 Global Others Price (2013-2018)
11 Global Cancer Pain Market Segment by Application
11.1 Global Cancer Pain Sales Market Share by Application (2013-2018)
11.2 Paracetamol Treatment-Related Immunotherapy Sales Growth (2013-2018)
11.3 Radiotherapy Sales Growth (2013-2018)
11.4 Chemotherapy Sales Growth (2013-2018)
11.5 Hormone Therapy Sales Growth (2013-2018)
12 Cancer Pain Market Forecast (2018-2023)
12.1 Global Cancer Pain Sales, Revenue and Growth Rate (2018-2023)
12.2 Cancer Pain Market Forecast by Regions (2018-2023)
12.2.1 North America Cancer Pain Market Forecast (2018-2023)
12.2.2 Europe Cancer Pain Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cancer Pain Market Forecast (2018-2023)
12.2.4 South America Cancer Pain Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cancer Pain Market Forecast (2018-2023)
12.3 Cancer Pain Market Forecast by Type (2018-2023)
12.3.1 Global Cancer Pain Sales Forecast by Type (2018-2023)
12.3.2 Global Cancer Pain Market Share Forecast by Type (2018-2023)
12.4 Cancer Pain Market Forecast by Application (2018-2023)
12.4.1 Global Cancer Pain Sales Forecast by Application (2018-2023)
12.4.2 Global Cancer Pain Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Cancer Pain Picture
Table Product Specifications of Cancer Pain
Figure Global Sales Market Share of Cancer Pain by Types in 2017
Table Cancer Pain Types